AC Immune SA (ACIU)
3.25
-0.16
(-4.69%)
USD |
NASDAQ |
May 17, 12:37
AC Immune Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -32.05% |
| September 30, 2023 | |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | -1.88M% |
| September 30, 2022 | -343.6% |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | -2.07K% |
| September 30, 2020 | -1.69K% |
| June 30, 2020 | -1.45K% |
| March 31, 2020 | -62.61% |
| December 31, 2019 | -2.26K% |
| September 30, 2019 | 54.85% |
| Date | Value |
|---|---|
| June 30, 2019 | -1.12K% |
| March 31, 2019 | 84.72% |
| December 31, 2018 | -1.31K% |
| September 30, 2018 | -586.4% |
| June 30, 2018 | -549.5% |
| March 31, 2018 | -796.6% |
| December 31, 2017 | 25.36% |
| September 30, 2017 | -818.7% |
| June 30, 2017 | -1.64K% |
| March 31, 2017 | -471.3% |
| December 31, 2016 | -333.4% |
| September 30, 2016 | -682.8% |
| June 30, 2016 | 64.84% |
| March 31, 2016 | -1.27K% |
| December 31, 2015 | -1.77K% |
| September 30, 2015 | 82.46% |
| June 30, 2015 | 60.62% |
| March 31, 2015 | -1.26K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-1.88M%
Minimum
Dec 2022
54.85%
Maximum
Sep 2019
-188.4K%
Average
-1.29K%
Median
Profit Margin (Quarterly) Benchmarks
| CRISPR Therapeutics AG | -- |
| Addex Therapeutics Ltd | -1.86K% |
| NLS Pharmaceutics Ltd | -- |
| Molecular Partners AG | -1.92K% |
| MoonLake Immunotherapeutics | -- |